Giving patients fixed-dose ‘polypills’ combining four commonly available generic drugs could reduce the rates of cardiovascular disease among people with “low socioeconomic status” and “non-white persons” in the US, suggest the results of a randomized trial reported in the New England Journal of Medicine.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?